skip to content

Centre for Advanced Photonics and Electronics


CAPE Acorn Fund – Call for 4th Year Project Proposals

For the seventh year running, the CAPE Acorn Fund seeks to support a range of small projects, with emphasis on promoting research proposed by young student researchers.  

Undergraduate students who are considering putting forward an industrial based type-(b) project topic for their 4th Year Project are invited to submit a brief proposal, no more than 2 pages of A4, to:

The CAPE Coordinator,
CAPE Office,
9 JJ Thomson Avenue,
Cambridge, CB3 0FA

The deadline for submission is Tuesday, 29 March 2022.   

Each proposal will be evaluated by the CAPE office for funding in association with one or more of the CAPE Partner companies.  Through the CAPE Office, students who are interested could approach the CAPE Partners of their choice with their project ideas, and then formulate their project before submitting their proposals.  The CAPE Office will be able to facilitate appropriate contact with the CAPE Partner companies. Students who have their own industrial partner are also welcome to apply and use CAUPA as an additional funding opportunity.

All applicants must agree to the CAPE Acorn Fund IP Terms and Conditions.

The successful candidates will receive a CAPE 4th Year Project Award, which includes project funding through CAPE at the standard 4th Year Project level (£250) and a £250 cash prize in a form of cheque to the winner.  They will then be invited to present their project results to the CAPE Steering Committee during the CAPE Event in June 2023.

About CAPE

The Centre for Advanced Photonics and Electronics (CAPE) is based around world-leading facilities and expertise at the University of Cambridge.  It is a Partnership between the University and a small group of global strategic industrial investors, operating across the supply chain of the electronics and photonics industries.  Current CAPE Partners are Beijing Institute of Aerospace Control Devices (BIACD), CRRC Zhuzhou Institute, Huawei Technologies, and GlaxoSmithCline (GSK) Healthcare.  CAPE provides a form of joint university-industry research that is leading edge, vertically integrated and commercially relevant.